Cognitive enhancement

Wiley Interdisciplinary Reviews: Cognitive Science

Volumn 5, Issue 1, 2014, Pages 95-103

  Farah, Martha J ^a   Smith, M Elizabeth ^a   Ilieva, Irena ^a   Hamilton, Roy H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890354851     PISSN: 19395078     EISSN: 19395086     Source Type: Journal    
DOI: 10.1002/wcs.1250     Document Type: Article

References (62)

1. Smith PJ, Blumenthal JA, Hoffman BM, Cooper H, Strauman TA, Welsh-Bohmer K, Browndyke JN, Sherwood A. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med 2010, 72:239-252.
2. Chiesa A, Calati R, Serretti A. Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. Clin Psychol Rev 2011, 31:449-464.
3. Morganthaler J, Dean W, Fowkes SW. Smart Drugs II: The New Generation of Drugs and Nutrients to Improve Your Memory and Increase Your Intelligence. Petaluma, CA: Smart Publications; 1993.
4. Centers for Disease Control and Prevention (CDC). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children: United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep 2010, 59:1439-1443.
5. Sankaranarayanan J, Puumala SE, Kratochvil CJ. Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003. Curr Med Res Opin 2006, 22:1475-1491.
6. MTA Cooperative Group. 14-month randomized clinical trail of treatment strategies for attention deficit hyperactivity disorder. Arch Gen Psychiatry 1999, 56:1073-1086.
7. Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, et al. Evidence, interpretation and qualification from multiple reports of long-term outcomes in the Multimodal treatment Study of Children with ADHD (MTA): Part II. Supporting details. J Attent Disord 2008, 12:15-43.
8. Robbins TW, Arnsten AF. The neuropsychopharmacology of fronto-executive function: monoaminergic modulations. Annu Rev Neurosci 2009, 32:267-287.
9. Volkow ND, Wang G, Newcorn J. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2007, 64:932-940.
10. Pliszka SR. The neuropsychopharmacology of attention-deficit/ hyperactivity disorder. Biol Psychiatry 2005, 57:1385-1390.
11. Wilens TE. Mechanism of action of agents used in attention-deficit/ hyperactivity disorder. J Clin Psychiatry 2006, 67:32-38.
12. Furey ML. The prominent role of stimulus processing: cholinergic function and dysfunction in cognition. Curr Opin Neurol 2011, 24:364-370.
13. Wesensten NJ. Effects of modafinil on cognitive performance and alertness during sleep deprivation. Curr Pharm Des 2006, 12:2457-2471.
14. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 2003, 165:260-269.
15. Minzenberg MJ, Carter CS. Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology 2008, 33:1477-1502.
16. Maeda F, Pascual-Leone A. Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders. Psychopharmacology 2003, 168:359-376.
17. Sack AT, Cohen Kadosh R, Schuhmann T, Moerel M, Walsh V, Goebel R. Optimizing functional accuracy of TMS in cognitive studies: a comparison of methods. J Cogn Neurosci 2009, 21:207-221.
18. Naeser MA, Martin PI, Nicholas M, Baker EH, Seekins H, Kobayashi M, Theoret H, Fregni F, Maria-Tormos J, Kurland J, et al. Improved picture naming in chronic aphasia after TMS to part of right Broca's area: an open-protocol study. Brain Lang 2005, 93:95-105.
19. Hamilton RH, Sanders L, Benson J, Faseyitan O, Norise C, Naeser M, Martin P, Coslet HB. Stimulating conversation: enhancement of elicited propositional speech in a patient with chronic non-fluent aphasia following transcranial magnetic stimulation. Brain Lang 2010, 113:45-50.
20. Najib U, Bashir S, Edwards D, Rotenberg A, Pascual-Leone A. Transcranial brain stimulation: clinical applications and future directions. Neurosurg Clin North Am 2011, 22:233-251.
21. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 2000, 572:633-639.
22. Priori A. Brain polarization in humans: a reappraisal of an old tool for prolonged non-invasive modulation of brain excitability. Clin Neurophysiol 2003, 114:589-595.
23. Datta A, Bansal V, Diaz J, Patel J, Reato D, Bikson M. Gyri-precise head model of transcranial direct current stimulation: improved spatial focality using a ring electrode versus conventional rectangular pad. Brain Stimul 2009, 2:201-207.
24. Utz KS, Dimova V, Oppenlander K, Kerkhoff G. Electrified minds: transcranial direct current stimulation (tDCS) and galvanic vestibular stimulation (GVS) as methods of non-invasive brain stimulation in neuropsychology-a review of current data and future implications. Neuropsychologia 2010, 48:2789-2810.
25. Kanai R, Chaieb L, Antal A, Walsh V, Paulus W. Frequency-dependent electrical stimulation of the visual cortex. Curr Biol 2008, 18:1839-1843.
26. Terney D, Chaieb L, Moliadze V, Antal A, Paulus W. Increasing human brain excitability by transcranial high-frequency random noise stimulation. J Neurosci 2008, 28:14147-14155.
27. Ioannidis JP. Why most published research findings are false. PLoS Med 2005, 2:e124. doi:10.1371/journal.pmed.0020124.
28. Simmons JP, Nelson LD, Simonsohn U. False-positive psychology. Psychol Sci 2011, 22:1359-1366.
29. Chamberlain SR, Robbins TW, Winder-Rhodes S, Muller U, Sahakian BJ, Blackwell AD, Barnet JH. Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry 2010, 69:1192-1203.
30. Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 2010, 62:187-206.
31. Hall WD, Lucke JC. Enhancement uses of neuropharmaceuticals: more caution and skepticism needed. Addiction 2010, 105:2041-2043.
32. Advokat C. What are the cognitive effects of stimulant medication? Emphasis on adults with attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev 2010, 34:1256-1266.
33. Farah MJ, Haimm C, Sankoorikal G, Smith ME, Chatterjee A. When we enhance cognition with Adderall do we sacrifice creativity? A preliminary study. Psychopharmacology 2008, 202:541-547.
34. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Weinberger DR. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response toamphetamine. Proc Natl Acad Sci U S A 2003, 100:6186-6191. doi: 10.1073/pnas.0931309100.
35. Smith ME, Farah MJ. Are prescription stimulants 'smart pills'? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull 2011, 137:717-741.
36. Ilieva I, Boland J, Farah MJ. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. Neuropharmacology 2013, 63:496-505.
37. DeSantis AD, Webb EM, Noar SM. Illicit use of prescription ADHD medications on a college campus: a multi-methodological approach. J Am Coll Heal 2008, 57:315-324.
38. Ilieva IP, Farah, MJ. Enhancement stimulants: perceived motivational and cognitive advantages. Frontiers in Neuropharmacology, in press.
39. Vrecko S. Just how cognitive is 'cognitive enhancement'? On the significance of emotions in university students' experiences with study drugs. AJOB Neurosci 2013, 4:4-12.
40. Hurst PM. A viewpoint on drug enhancement. Office of Naval Research Technical Report, 1966. Available at: www.dtic.mil/dtic/tr/fulltext/u2/635948.pdf.
41. Repantis D, Laisney O, Heuser I. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healhty individuals: a systematic review. Pharmacol Res 2010, 61:473-481.
42. Wesenten, NJ. Effects of modafinil on cognitive performance and alertness during sleep deprivation. Curr Pharm Des 2006, 12:2457-71.
43. Kelley, AM, Webb, CM, Athy, JR, Ley, S & Gaydos, S. (2012). Cognition enhancement by modafinil: a meta-analysis. Aviat Space Environ Med, 83, 685-690.
44. Volkow ND, Swanson JM. The action of enhancers can lead to addiction. Nature 2008, 451:521.
45. Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray RM, Penne MA. Nonmedical use of prescription stimulants in the United States. Drug and Alcohol Dependence 2006, 84:135-143.
46. Hamilton R, Messing S, Chatterjee A. Rethinking the thinking cap: ethics of neural enhancement using noninvasive brain stimulation. Neurology 2011, 76:187-193.
47. Cohen Kadosh R, Levy N, O'Shea J, Shea N, Savulescu J. The neuroethics of non-invasive brain stimulation. Curr Biol 2012, 22:R108-R111.
48. Cohen Kadosh R, Soskic S, Iuculano T, Kanai R, Walsh V. Modulating neuronal activity produces specific and long-lasting changes in numerical competence. Curr Biol 2010, 20:2016-2020.
49. Snowball A, Tachtsidis I, Popescu T, Thompson J, Delazer M, Zamarian L, Zhu T, Cohen KR. Long-term enhancement of brain function and cognition using cognitive training and brain stimulation. Curr Biol 2013, 23:987-992.
50. Chia RP, Snyder AW. Brain stimulation enables the solution of an inherently difficult problem. Neurosci Lett 2012, 515:121-124.
51. Koenigs M, Ukueberuwa D, Campion P, Grafman J, Wassermann E. Bilateral frontal transcranial direct current stimulation: failure to replicate classic findings in healthy subjects. Clin Neurophysiol 2009, 20:80-84.
52. Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009, 120:2009-2039.
53. Kessler SK, Turkeltaub PE, Benson JG, Hamilton RH. Differences in the experience of active and sham transcranial direct current stimulation. Brain Stimul 2012, 5:155-162.
54. Maher B. Poll results: Look who's doping. Nature 2008, 452:674-675.
55. Madrigal A. Readers' Brain-Enhancing Drug Regimens. Wired Magazine, April 24, 2008.
56. McCabe SE, Knight JR, Teter CJ, Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005, 100:96-106.
57. Teter CI, McCabe SE, Cranford JA, Boyd CI, Guthrie SK. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Heal 2005, 53:253-262.
58. Franke AG. Non-Medical Use of Prescription Stimulants and Illicit Use of Stimulants for Cognitive Enhancement in Pupils and Students in Germany. Pharmacopsychiatry 2011, 44:60-66.
59. Partridge B, Bell S, Lucke J, Hall W. Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety. Drug Alcohol Rev 2013, 32:295-302.
60. Ragan CI, Bard I, Singh I. What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology 2013, 64:588-595.
61. Adee S. Zap your brain into the zone: fast track to pure focus. New Scient 2012, 2850:32-35.
62. Oremus, W. A new technology promises to supercharge your brain with electricity. Is it too good to be true? Slate, April 1, 2013.